Skip to content
OpenCapital
Get started

Intensity Therapeutics, Inc. INTS Q1 2026 earnings

Reported May 7, 2026 · Before market open

EPS-$0.96Beat by $0.23
EPS estimate-$1.19

Next report

Aug 6, 2026 (In 1 week)
EPS estimate-$0.87

Versus estimates

Diluted EPS

Q1 2026-$0.96Beat by $0.23
Q4 2025$1.69Beat by $2.93Q3 2025-$0.06In lineQ2 2025-$0.13Miss by $0.07Q1 2025-$0.22Miss by $0.01Q4 2024-$0.22Beat by $0.01

Ask the moment Intensity Therapeutics, Inc. reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Intensity Therapeutics, Inc. report Q1 2026 earnings?
Intensity Therapeutics, Inc. (INTS) reported Q1 2026 earnings on May 7, 2026 before market open.
What were Intensity Therapeutics, Inc.'s Q1 2026 revenue and EPS?
Intensity Therapeutics, Inc. reported eps of $-0.96 for Q1 2026.
Did Intensity Therapeutics, Inc. beat estimates in Q1 2026?
EPS beat the consensus estimate of $-1.19 by $0.23.
How did Intensity Therapeutics, Inc.'s Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, eps declined 336.4% from $-0.22.
Where can I find Intensity Therapeutics, Inc.'s Q1 2026 SEC filings?
You can read the 8-K earnings release (0001567264-26-000047) and the 10-Q periodic report (0001567264-26-000046) directly on SEC EDGAR. The filing index links above go to sec.gov.